The emerging treatment of this peptide represents a significant development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide022569.win-blog.com/23402679/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment